-
Something wrong with this record ?
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
S. El-Ashwah, J. Salmanton-García, YM. Bilgin, F. Itri, P. Žák, B. Weinbergerová, L. Verga, AS. Omrani, MGD. Silva, T. Szotkowski, M. Marchetti, C. Buquicchio, M. Nucci, M. Schönlein, F. Farina, C. Besson, L. Prezioso, S. Nizamuddin, J....
Language English Country United States
Document type Journal Article
- MeSH
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive * epidemiology MeSH
- COVID-19 * MeSH
- Hematologic Neoplasms * MeSH
- Hospitalization MeSH
- Humans MeSH
- Pandemics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Since the beginning of the COVID-19 pandemic, there has been an overall improvement in patient mortality. However, haematological malignancy patients continue to experience significant impacts from COVID-19, including high rates of hospitalization, intensive care unit (ICU) admissions, and mortality. In comparison to other haematological malignancy patients, individuals with chronic myeloid leukemia (CML) generally have better prognosis. This study, conducted using a large haematological malignancy patient database (EPICOVIDEHA), demonstrated that the majority of CML patients experienced mild infections. The decline in severe and critical infections over the years can largely be attributed to the widespread administration of vaccinations and the positive response they elicited. Notably, the mortality rate among CML patients was low and exhibited a downward trend in subsequent years. Importantly, our analysis provided confirmation of the effectiveness of vaccinations in CML patients.
1 Department of Medicine University Medical Center Hamburg Eppendorf Hamburg Germany
3 Department of Medicine University Medical Center Hamburg Eppendorf Hamburg Germany
Amsterdam UMC Location VUmc Amsterdam Netherlands
Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo Alessandria Italy
Azienda Ospedaliera San Gerardo Monza Monza Italy
Centre Hospitalier de Versailles Le Chesnay France
Clinic for Orthopedic Surgery and Traumatology University Clinical Center of Serbia Belgrade Serbia
Clinical Trials Centre Cologne University of Cologne University Hospital Cologne Cologne Germany
Communicable Disease Center Hamad Medical Corporation Doha Qatar
Complejo Hospitalario de Navarra Iruña Pamplona Spain
COVID 19 Hospital Batajnica Belgrade Serbia
Department of Clinical and Biological Sciences University of Turin Turin Italy
Department of Hematology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark
Department of Hematology Research Unit Hospital Universitario de Burgos Burgos Spain
Department of Hematology UZ Leuven Leuven Belgium
Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden
Department of Internal Medicine ADRZ Goes Netherlands
Department of Medicine Section of Hematology University of Verona Verona Italy
Department of Microbiology Immunology and Transplantation KULeuven Leuven Belgium
Division of Hematology Dokuz Eylul University Izmir Turkey
Ematologia con Trapianto Ospedale Dimiccoli Barletta Barletta Italy
Federal University of Rio de Janeiro Rio de Janeiro Brazil
Fundacion Jimenez Diaz University Hospital Health Research Institute IIS FJD Madrid Spain
German Centre for Infection Research Partner Site Bonn Cologne Cologne Germany
Hematology and Stem Cell Transplant Unit IRCCS Regina Elena National Cancer Institute Rome Italy
Hematology Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy
Hematology Unit Università Cattolica del Sacro Cuore Rome Italy
Hospital Escuela de Agudos Dr Ramón Madariaga Posadas Argentina
Hospital Nuestra Señora de Sonsoles Ávila Spain
Hospital Universitario 12 de Octubre Madrid Spain
Hospital University of Parma Hematology and Bone Marrow Unit Parma Italy
Institute of Hematology and Blood Transfusion Prague Czech Republic
IRCCS Ospedale San Raffaele Milan Italy
King's College Hospital London UK
Memorial Cancer Hospital and Research Centre Lahore Pakistan
NIHR Oxford Biomedical Research Centre Churchill Hospital Oxford UK
Oncology Center Mansoura University Mansoura Egypt
Ospedale San Bortolo Vicenza Italy
Portuguese Institute of Oncology Lisbon Portugal
San Luigi Gonzaga Hospital Orbassano Orbassano Italy
Shaukat Khanum Memorial Cancer Hospital and Research Centre Lahore Pakistan
Sultan Qaboos University Hospital Muscat Oman
Università Milano Bicocca Milan Italy
Université Paris Saclay UVSQ Inserm Équipe Exposome et Hérédité CESP Villejuif France
University Hospital Hradec Králové Hradec Králové Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007409
- 003
- CZ-PrNML
- 005
- 20240423155930.0
- 007
- ta
- 008
- 240412s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/10428194.2023.2280886 $2 doi
- 035 __
- $a (PubMed)37966980
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a El-Ashwah, Shaimaa $u Oncology Center, Mansoura University, Mansoura, Egypt $1 https://orcid.org/0000000322101534
- 245 14
- $a The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey / $c S. El-Ashwah, J. Salmanton-García, YM. Bilgin, F. Itri, P. Žák, B. Weinbergerová, L. Verga, AS. Omrani, MGD. Silva, T. Szotkowski, M. Marchetti, C. Buquicchio, M. Nucci, M. Schönlein, F. Farina, C. Besson, L. Prezioso, S. Nizamuddin, J. Dávila-Valls, S. Martín-Pérez, V. Bonuomo, J. Van Doesum, MC. Tisi, F. Passamonti, GA. Méndez, S. Meers, J. Maertens, A. López-García, A. Glenthøj, M. Bonnani, I. Rinaldi, I. Ormazabal-Vélez, J. Labrador, A. Kulasekararaj, I. Espigado, F. Demirkan, N. De Jonge, GP. Collins, M. Calbacho, O. Blennow, M. Al-Khabori, T. Adžić-Vukičević, E. Arellano, B. Mišković, M. Mladenović, A. Nordlander, Z. Ráčil, E. Ammatuna, R. Cordoba, DS. Hersby, S. Gräfe, Z. Emarah, M. Hanakova, MV. Sacchi, M. Ijaz, L. Rahimli, R. Nunes Rodrigues, GPM. Zambrotta, F. Marchesi, OA. Cornely, L. Pagano
- 520 9_
- $a Since the beginning of the COVID-19 pandemic, there has been an overall improvement in patient mortality. However, haematological malignancy patients continue to experience significant impacts from COVID-19, including high rates of hospitalization, intensive care unit (ICU) admissions, and mortality. In comparison to other haematological malignancy patients, individuals with chronic myeloid leukemia (CML) generally have better prognosis. This study, conducted using a large haematological malignancy patient database (EPICOVIDEHA), demonstrated that the majority of CML patients experienced mild infections. The decline in severe and critical infections over the years can largely be attributed to the widespread administration of vaccinations and the positive response they elicited. Notably, the mortality rate among CML patients was low and exhibited a downward trend in subsequent years. Importantly, our analysis provided confirmation of the effectiveness of vaccinations in CML patients.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a COVID-19 $7 D000086382
- 650 _2
- $a pandemie $7 D058873
- 650 12
- $a chronická myeloidní leukemie $x epidemiologie $7 D015464
- 650 _2
- $a hospitalizace $7 D006760
- 650 12
- $a hematologické nádory $7 D019337
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Salmanton-García, Jon $u Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, University Hospital Cologne, Institute of Translational Research, Cologne, Germany $u Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University of Cologne, University Hospital Cologne, Cologne, Germany $1 https://orcid.org/0000000267668297
- 700 1_
- $a Bilgin, Yavuz M $u Department of Internal Medicine, ADRZ, Goes, Netherlands $1 https://orcid.org/0000000237833407
- 700 1_
- $a Itri, Federico $u San Luigi Gonzaga Hospital - Orbassano, Orbassano, Italy $1 https://orcid.org/0000000235325281
- 700 1_
- $a Žák, Pavel $u University Hospital Hradec Králové, Hradec Králové, Czech Republic $1 https://orcid.org/0000000344655343
- 700 1_
- $a Weinbergerová, Barbora $u Department of Internal Medicine - Hematology and Oncology, Masaryk University Hospital Brno, Brno, Czech Republic $1 https://orcid.org/0000000164602471
- 700 1_
- $a Verga, Luisa $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy $u Università Milano-Bicocca, Milan, Italy $1 https://orcid.org/0000000208683358
- 700 1_
- $a Omrani, Ali S $u Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar $1 https://orcid.org/0000000153096358
- 700 1_
- $a Silva, Maria Gomes da $u Portuguese Institute of Oncology, Lisbon, Portugal $1 https://orcid.org/0000000269932450
- 700 1_
- $a Szotkowski, Tomáš $u University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Marchetti, Monia $u Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy $1 https://orcid.org/0000000176150572
- 700 1_
- $a Buquicchio, Caterina $u Ematologia con Trapianto, Ospedale Dimiccoli Barletta, Barletta, Italy $1 https://orcid.org/0000000236835953
- 700 1_
- $a Nucci, Marcio $u Federal University of Rio de Janeiro, Rio de Janeiro, Brazil $1 https://orcid.org/0000000348670014
- 700 1_
- $a Schönlein, Martin $u Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany $1 https://orcid.org/0000000210100975
- 700 1_
- $a Farina, Francesca $u IRCCS Ospedale San Raffaele, Milan, Italy $1 https://orcid.org/0000000251246970
- 700 1_
- $a Besson, Caroline $u Centre Hospitalier de Versailles, Le Chesnay, France $u Université Paris-Saclay, UVSQ, Inserm, Équipe "Exposome et Hérédité", CESP, Villejuif, France $1 https://orcid.org/0000000343647173
- 700 1_
- $a Prezioso, Lucia $u Hospital University of Parma - Hematology and Bone Marrow Unit, Parma, Italy $1 https://orcid.org/0000000316604960
- 700 1_
- $a Nizamuddin, Summiya $u Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
- 700 1_
- $a Dávila-Valls, Julio $u Hospital Nuestra Señora de Sonsoles, Ávila, Spain $1 https://orcid.org/0000000251852073
- 700 1_
- $a Martín-Pérez, Sonia $u Hospital Nuestra Señora de Sonsoles, Ávila, Spain $1 https://orcid.org/0000000158097165
- 700 1_
- $a Bonuomo, Valentina $u Department of Medicine, Section of Hematology, University of Verona, Verona, Italy $u Department of Clinical and Biological Sciences, University of Turin, Turin, Italy $1 https://orcid.org/0000000164918337
- 700 1_
- $a Van Doesum, Jaap $u University Medical Center Groningen, Groningen, Netherlands $1 https://orcid.org/0000000302143219
- 700 1_
- $a Tisi, Maria Chiara $u Ospedale San Bortolo, Vicenza, Italy $1 https://orcid.org/0000000182316700
- 700 1_
- $a Passamonti, Francesco $u Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy $1 https://orcid.org/0000000180685289
- 700 1_
- $a Méndez, Gustavo-Adolfo $u Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina $1 https://orcid.org/0000000305147004
- 700 1_
- $a Meers, Stef $u AZ KLINA, Brasschaat, Belgium $1 https://orcid.org/0000000317542175
- 700 1_
- $a Maertens, Johan $u Department of Microbiology, Immunology, and Transplantation, KULeuven, Leuven, Belgium $u Department of Hematology, UZ Leuven, Leuven, Belgium $1 https://orcid.org/0000000342575980
- 700 1_
- $a López-García, Alberto $u Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain $1 https://orcid.org/0000000253545261
- 700 1_
- $a Glenthøj, Andreas $u Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark $1 https://orcid.org/0000000320820738
- 700 1_
- $a Bonnani, Matteo $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy $1 https://orcid.org/0000000317756333
- 700 1_
- $a Rinaldi, Ikhwan $u Division of Hematology and Medical Oncology, Department of Internal Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
- 700 1_
- $a Ormazabal-Vélez, Irati $u Complejo Hospitalario de Navarra, Iruña-Pamplona, Spain $1 https://orcid.org/0000000311415546
- 700 1_
- $a Labrador, Jorge $u Department of Hematology, Research Unit, Hospital Universitario de Burgos, Burgos, Spain $1 https://orcid.org/0000000236960287
- 700 1_
- $a Kulasekararaj, Austin $u King's College Hospital, London, UK $1 https://orcid.org/0000000331803570
- 700 1_
- $a Espigado, Ildefonso $u Department of Hematology, University Hospital Virgen Macarena - University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Universidad de Sevilla (Departamento de Medicina), Seville, Spain $1 https://orcid.org/0000000240436613
- 700 1_
- $a Demirkan, Fatih $u Division of Hematology, Dokuz Eylul University, Izmir, Turkey $1 https://orcid.org/0000000211728668
- 700 1_
- $a De Jonge, Nick $u Amsterdam UMC, Location VUmc, Amsterdam, Netherlands $1 https://orcid.org/0000000299010887
- 700 1_
- $a Collins, Graham P $u NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK
- 700 1_
- $a Calbacho, Maria $u Hospital Universitario 12 de Octubre, Madrid, Spain $1 https://orcid.org/0000000181064863
- 700 1_
- $a Blennow, Ola $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden $1 https://orcid.org/0000000271677882
- 700 1_
- $a Al-Khabori, Murtadha $u Sultan Qaboos University Hospital, Muscat, Oman $1 https://orcid.org/0000000229378838
- 700 1_
- $a Adžić-Vukičević, Tatjana $u COVID-19 Hospital "Batajnica", Belgrade, Serbia
- 700 1_
- $a Arellano, Elena $u Department of Hematology, University Hospital Virgen Macarena - University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Universidad de Sevilla (Departamento de Medicina), Seville, Spain
- 700 1_
- $a Mišković, Bojana $u COVID-19 Hospital "Batajnica", Belgrade, Serbia $u Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Serbia, Belgrade, Serbia
- 700 1_
- $a Mladenović, Miloš $u COVID-19 Hospital "Batajnica", Belgrade, Serbia $u Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Serbia, Belgrade, Serbia $1 https://orcid.org/0000000283502182
- 700 1_
- $a Nordlander, Anna $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Ráčil, Zdeněk $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic $1 https://orcid.org/0000000335114596
- 700 1_
- $a Ammatuna, Emanuele $u University Medical Center Groningen, Groningen, Netherlands $1 https://orcid.org/0000000182474901
- 700 1_
- $a Cordoba, Raul $u Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain $1 https://orcid.org/0000000276548836
- 700 1_
- $a Hersby, Ditte Stampe $u Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark $1 https://orcid.org/0000000229998949
- 700 1_
- $a Gräfe, Stefanie $u Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, University Hospital Cologne, Institute of Translational Research, Cologne, Germany $u I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany $u III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany $1 https://orcid.org/0000000176780179
- 700 1_
- $a Emarah, Ziad $u Oncology Center, Mansoura University, Mansoura, Egypt $1 https://orcid.org/0000000306222598
- 700 1_
- $a Hanakova, Michaela $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Sacchi, Maria Vittoria $u Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy $1 https://orcid.org/0000000181333357
- 700 1_
- $a Ijaz, Marriyam $u Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
- 700 1_
- $a Rahimli, Laman $u Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, University Hospital Cologne, Institute of Translational Research, Cologne, Germany $1 https://orcid.org/000000032266445X
- 700 1_
- $a Nunes Rodrigues, Raquel $u Portuguese Institute of Oncology, Lisbon, Portugal $1 https://orcid.org/0000000283474281
- 700 1_
- $a Zambrotta, Giovanni Paolo Maria $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy $u Università Milano-Bicocca, Milan, Italy $1 https://orcid.org/0000000286122994
- 700 1_
- $a Marchesi, Francesco $u Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy $1 https://orcid.org/0000000163532272
- 700 1_
- $a Cornely, Oliver A $u Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, University Hospital Cologne, Institute of Translational Research, Cologne, Germany $u Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, University Hospital Cologne, Cologne, Germany $u Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine, and University Hospital Cologne, Cologne, Germany $u German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany $1 https://orcid.org/0000000195993137
- 700 1_
- $a Pagano, Livio $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy $u Hematology Unit, Università Cattolica del Sacro Cuore, Rome, Italy $1 https://orcid.org/000000018287928X
- 773 0_
- $w MED00003140 $t Leukemia & lymphoma $x 1029-2403 $g Roč. 65, č. 2 (2024), s. 199-208
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37966980 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155926 $b ABA008
- 999 __
- $a ok $b bmc $g 2081404 $s 1217176
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 65 $c 2 $d 199-208 $e 20240124 $i 1029-2403 $m Leukemia & lymphoma $n Leuk Lymphoma $x MED00003140
- LZP __
- $a Pubmed-20240412
